Extended report
Detection and identification of antinuclear antibodies (ANA) in a
large and consecutive cohort of serum samples referred for ANA testing
I Peenea, L Meheusb, E M Veysa, F De Keysera
a Department of
Rheumatology, Ghent University Hospital, Belgium, b Innogenetics NV, Ghent, Belgium
Correspondence to: Dr F De Keyser, Department of Rheumatology 0K12IB, University Hospital Ghent, De pintelaan 185, 9000 Ghent, Belgium filip.dekeyser{at}rug.ac.be
Accepted for publication 3 May 2001
OBJECTIVE
To provide
data on (a) the probability of detecting
antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing and (b) the
probability of detecting more specific antinuclear reactivities
(anti-DNA and anti-extractable nuclear antigens (anti-ENA)) in serum
samples with a positive screening test (indirect immunofluorescence on
HEp-2 cells).
METHODS
Serum
samples from 10 550 consecutive patients sent to the laboratory for
ANA detection were analysed. In ANA positive serum samples (23.5% of
referred serum samples), ANA were identified by indirect
immunofluorescence on Crithidia, by
immunodiffusion, and by line immunoassay. Because anti-SSA
antibodies were the most frequently identified ANA, sensitively
detected by line immunoassay, additional immunoassays were developed to
confirm the specificity of the line immunoassay result.
RESULTS
At least one
fine reactivity could be identified in 21.1% of ANA positive serum
samples: anti-dsDNA in 3.2%; anti-ENA (anti-SSA 10.5%, anti-SSB
6.7%, anti-RNP 2.7%, anti-Sm 1.8%, anti-Scl70 1.2%, anti-Jo-1
0.2%) in 15.8%, rRNP and anti-Cenp-B in respectively 0.5% and 4.0%.
Multiple reactivities were found in 7.9%. For anti-ENA antibodies,
line immunoassay was more sensitive than immunodiffusion (15.4%
v 7.7%; p<0.0001). The sensitive detection
of anti-SSA antibodies by line immunoassay was confirmed by additional assays.
CONCLUSIONS
The data
from this analysis are useful in estimating the probabilities of
detecting specific ANA. Line immunoassay was shown to be a
sensitive test for the detection of anti-ENA antibodies.
© 2001 by Annals of the Rheumatic Diseases
This article has been cited by other articles:
-
Smith, V, Vanthuyne, M, Vander Cruyssen, B, Van Praet, J, Vermeiren, F, Smets, H, Houssiau, F, De Keyser, F
(2008). Over-representation of construction-related occupations in male patients with systemic sclerosis. Ann Rheum Dis
67: 1448-1450
[Abstract] [Full Text] -
Binder, S.
(2006). Autoantibody Detection Using Multiplex Technologies. Lupus
15: 412-421
[Abstract] -
Pham, B-N, Albarede, S, Guyard, A, Burg, E, Maisonneuve, P
(2005). Impact of external quality assessment on antinuclear antibody detection performance. Lupus
14: 113-119
[Abstract] -
Hoffman, I E A, Peene, I, Meheus, L, Huizinga, T W J, Cebecauer, L, Isenberg, D, De Bosschere, K, Hulstaert, F, Veys, E M, De Keyser, F
(2004). Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis
63: 1155-1158
[Abstract] [Full Text] -
Hoffman, I. E.A., Peene, I., Veys, E. M., De Keyser, F.
(2002). Detection of Specific Antinuclear Reactivities in Patients with Negative Anti-nuclear Antibody Immunofluorescence Screening Tests. Clin. Chem.
48: 2171-2176
[Abstract] [Full Text] -
Peene, I, Meheus, L, Veys, E M, De Keyser, F
(2002). Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype. Ann Rheum Dis
61: 1090-1094
[Abstract] [Full Text] -
Peene, I, Meheus, L, De Keyser, S, Humbel, R, Veys, E M, De Keyser, F
(2002). Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease. Ann Rheum Dis
61: 929-933
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
